Nasdaq

BIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW STANDARD IN SPATIAL BIOLOGY WITH PROTEASE-FREE RNASCOPE MULTIOMICS

Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, achieves technical breakthrough enabling protease-free, same-slide detection of protein and RNA biomarkers using industry-leading ...
Nasdaq

Bio-Techne, Akoya To End Co-development Of RNAscope For Use With PhenoCycler-Fusion System

(RTTNews) - Life sciences company Bio-Techne Corp. (TECH) announced Monday that the company will end their collaboration with Akoya Biosciences to co-develop an automated RNAscope workflow for use ...
Fox 5 San Diego

BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION

MINNEAPOLIS, Aug. 14, 2023 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic ...
The Victoria Advocate

Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025

MINNEAPOLIS, May 12, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest spatial biology and cell and gene therapy workflow solutions at the American ...
technologynetworks

Bio-Techne Expands RNAscope® Assay Services Portfolio

Bio-Techne has added new capabilities and options to its Advanced Cell Diagnostics (ACD)-branded RNAscope® and BaseScope™ in situ hybridization (ISH) Assay Services Portfolio to improve biotech and ...